Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How to use PET/CT in the evaluation of response to radiotherapy.
Decazes P, Thureau S, Dubray B, Vera P. Decazes P, et al. Among authors: thureau s. Q J Nucl Med Mol Imaging. 2018 Jun;62(2):152-164. doi: 10.23736/S1824-4785.17.03033-3. Epub 2017 Nov 28. Q J Nucl Med Mol Imaging. 2018. PMID: 29186937 Free article. Review.
[Interest of FDG-PET for lung cancer radiotherapy].
Thureau S, Mezzani-Saillard S, Modzelewski R, Edet-Sanson A, Dubray B, Vera P. Thureau S, et al. Cancer Radiother. 2011 Oct;15(6-7):504-8. doi: 10.1016/j.canrad.2011.07.227. Epub 2011 Aug 30. Cancer Radiother. 2011. PMID: 21880535 Review. French.
[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique].
Chauvet B, Mahé MA, Maingon P, Mazeron JJ, Mornex F; Société française de radiothérapie oncologique (SFRO); Chauvet B, Mahé MA, Maingon P, Mazeron JJ, Mornex F, Azria D, Barillot I, Chauvet B, Denis F, Lartigau É, Lipinski F, Maingon P, Mornex F, Ardiet JM, Bibault JE, Caudrelier V, Diaz O, de Crevoisier R, Dubray B, Estivalet S, Faivre JC, Fenoglietto P, Fumagalli I, Ferlay J, Giraud P, Hennequin C, Henoch H, Khodri M, Llacer C, Lagrange JL, Lorchel F, Mahé MA, Meyrieux C, de Martel C, Noël G, Oozeer R, Peiffert D, Pointreau Y, Pourel N, Pradier O, Rocher F, Thureau S, Eschwège F, Martin P, Parmentier G. Chauvet B, et al. Among authors: thureau s. Cancer Radiother. 2013 Aug;17 Suppl 1:S2-72. doi: 10.1016/j.canrad.2013.04.002. Epub 2013 Jul 31. Cancer Radiother. 2013. PMID: 23916854 French. No abstract available.
Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Thureau S, Chaumet-Riffaud P, Modzelewski R, Fernandez P, Tessonnier L, Vervueren L, Cachin F, Berriolo-Riedinger A, Olivier P, Kolesnikov-Gauthier H, Blagosklonov O, Bridji B, Devillers A, Collombier L, Courbon F, Gremillet E, Houzard C, Caignon JM, Roux J, Aide N, Brenot-Rossi I, Doyeux K, Dubray B, Vera P. Thureau S, et al. J Nucl Med. 2013 Sep;54(9):1543-50. doi: 10.2967/jnumed.112.118083. Epub 2013 Aug 5. J Nucl Med. 2013. PMID: 23918733 Free article. Clinical Trial.
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2).
Vera P, Mezzani-Saillard S, Edet-Sanson A, Ménard JF, Modzelewski R, Thureau S, Meyer ME, Jalali K, Bardet S, Lerouge D, Houzard C, Mornex F, Olivier P, Faure G, Rousseau C, Mahé MA, Gomez P, Brenot-Rossi I, Salem N, Dubray B. Vera P, et al. Among authors: thureau s. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1057-65. doi: 10.1007/s00259-014-2687-9. Epub 2014 Feb 22. Eur J Nucl Med Mol Imaging. 2014. PMID: 24562641 Clinical Trial.
114 results